Intrathrombus polymer coating deposition: a pilot study of 91 patients undergoing endovascular therapy for acute large vessel stroke. Part I: Histologic frequency
Open Access
- 18 May 2019
- journal article
- research article
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 11 (12) , 1191-1196
Abstract
Background Polymer coating embolism due to vascular medical device use is an increasingly recognized iatrogenic complication. This phenomenon has been linked with various adverse effects including neuroinflammation, acute ischemic stroke, cerebral hemorrhage, and death. Notably, procedure- and device-specific risks of this complication are poorly investigated. In this study, we evaluate the detectable frequency of intra-arterial polymer coating delamination among patients who underwent endovascular thrombectomy for treatment of acute ischemic stroke due to large vessel occlusion. Methods Ninety-two cerebral thrombectomy specimens were retrospectively analyzed for the presence of polymer coating particulates. Histologic findings were correlated with demographic and procedural details and patient outcomes. Results Evidence of polymer coating deposition was found in 30 of 92 extracted thrombi (33%). No correlation between intrathrombus polymer deposition and use of a specific thrombectomy device such as a stent retriever, aspiration catheter, or guide catheter was found. However, heterogeneous patterns of device use suggest a number of culprit devices. A trend toward longer procedure times and multiple thrombectomy passes was noted in positive cases. Intrathrombus polymer deposition was not associated with adverse clinical outcomes as measured by the 90-day modified Rankin Scale (mRS); however, small sample size and follow-up intervals limit interpretation. Ninety-day outcomes based on mRS may not fully capture the clinical effects of acute and/or delayed intracerebral polymer complications. Conclusion In light of documented adverse neurologic effects, the frequency of intrathrombus polymer particulates indicates the need for consensus testing methods and large-scale long-term prospective clinical device trials, with inclusion of relevant endpoints to better assess biomaterial and device risks to patients.Keywords
Funding Information
- National Institute of General Medical Sciences
- National Institute of Neurological Disorders and Stroke
This publication has 25 references indexed in Scilit:
- Cerebral foreign body reaction due to hydrophilic polymer embolization following aneurysm treatment by pipeline flow diversion deviceInterventional Neuroradiology, 2019
- Significant Differences in Debris Captured by the Sentinel Dual-Filter Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Among Different Valve TypesJACC: Cardiovascular Interventions, 2018
- Hydrophilic polymer embolic complication during diagnostic cerebral angiography presenting with delayed intracranial hemorrhage: case report and literature reviewJournal of NeuroInterventional Surgery, 2018
- Hydrophilic Polymer Embolism: Implications for Manufacturing, Regulation, and Postmarket Surveillance of Coated Intravascular Medical DevicesJournal of Patient Safety, 2018
- Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion ImagingNew England Journal of Medicine, 2018
- Hydrophilic Polymer Embolism: An Update for PhysiciansThe American Journal of Medicine, 2017
- Foreign Body Emboli following Cerebrovascular Interventions: Clinical, Radiographic, and Histopathologic FeaturesAmerican Journal of Neuroradiology, 2015
- Neurological Changes with Abnormal Brain Reactivity Following Coiling of Cerebral Aneurysm. Possible Reactivity to Endovascular Devices and Material?2015
- Hydrophilic polymer embolism and associated vasculopathy of the lung: prevalence in a retrospective autopsy studyHuman Pathology, 2015
- Histopathological assessment of fatal ipsilateral intraparenchymal hemorrhages after the treatment of supraclinoid aneurysms with the Pipeline Embolization DeviceJournal of Neurosurgery, 2014